Clinical Trials
184
Active:59
Completed:65
Trial Phases
5 Phases
Phase 1:20
Phase 2:36
Phase 3:80
+2 more phases
Drug Approvals
272
EMC:229
CIMA_AEMPS:25
SFDA:9
+2 more agencies
Drug Approvals
Nirmatrelvir Tablets/Ritonavir Tablets（co-packaged）
- Product Name
- 瑞派乐
- Approval Number
- 国药准字HJ20220006
- Approval Date
- Feb 11, 2022
NMPA
Piperacillin Sodium and Tazobactam Sodium for Injection
- Product Name
- 特治星
- Approval Number
- H20140911
- Approval Date
- Nov 27, 2019
NMPA
Cefotiam Hydrochloride for Injection
- Product Name
- 注射用盐酸头孢替安
- Approval Number
- H20170185
- Approval Date
- Feb 13, 2019
NMPA
Clinical Trials
Distribution across different clinical trial phases (153 trials with phase data)• Click on a phase to view related trials
Phase 3
80 (52.3%)Phase 2
36 (23.5%)Phase 1
20 (13.1%)Phase 4
8 (5.2%)Not Applicable
4 (2.6%)phase_2_3
4 (2.6%)phase_1_2
1 (0.7%)No trials found
News
No news found